Edgestream Partners’s Integra LifeSciences IART Stock Holding History

Edgestream Partners’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-60,209	Closed	-$739K	–	965
2025 Q2	$739K	Buy	+60,209	New	+$874K	0.02%	688
2024 Q1	–	Sell	-34,818	Closed	-$1.52M	–	903
2023 Q4	$1.52M	Buy	+34,818	New	+$1.37M	0.11%	311
2021 Q4	–	Sell	-28,907	Closed	-$1.98M	–	520
2021 Q3	$1.98M	Sell	28,907 -33,420	-54%	-$2.36M	0.12%	240
2021 Q2	$4.25M	Buy	+62,327	New	+$4.41M	0.25%	141

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Edgestream Partners's IART Position: Q3 2025 in Review

Edgestream Partners sold out of Integra LifeSciences (IART) in Q3 2025, closing a stake of 60,209 shares — an estimated $739K sold.

Edgestream Partners first reported a position in IART in Q2 2021 and held it in 4 quarters. The position peaked at $4.25M in Q2 2021. 207 funds tracked by Wall St. Rank hold IART as of Q3 2025.

Edgestream Partners reported no remaining Integra LifeSciences position as of Q3 2025 after selling out during the quarter.
Edgestream Partners sold 60,209 Integra LifeSciences shares in Q3 2025, an estimated $739K.
Edgestream Partners first reported a position in Integra LifeSciences in Q2 2021 and held it in 4 quarters.
Edgestream Partners's Integra LifeSciences position peaked at $4.25M in Q2 2021.
207 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2025.

Based on Edgestream Partners's 13F filing for Q3 2025, filed 12 Nov 2025.